Business
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.https://clinicaltrials.gov/study/NCT07572890#study-overviewTo view an enhanced version of this graphic, please...
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.","length":349,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":401,"url":"https://media.zenfs.com/en/newsfile_64/ee94afde548e773100c499f698fb0da9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2I1e.DMqPS.sA9BZ1qZulA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcwMA--/https://media.zenfs.com/en/newsfile_64/ee94afde548e773100c499f698fb0da9","width":550,"height":401},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/kMDIlVV0FTydK4tAdFG3oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQ2Nw--/https://media.zenfs.com/en/newsfile_64/ee94afde548e773100c499f698fb0da9","width":550,"height":401}},"href":"https://images.newsfilecorp.com/files/10520/298208_kidneystudy.jpg","hrefExternal":true},{"type":"text","content":"https://clinicaltrials.gov/study/NCT07572890#study-overviewTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/298208_kidneystudy.jpg","length":186,"tagName":"p","attribs":{}},{"type":"text","content":"Each study is enrolling up to 100 participants. The Kidney Health Study (NCT07572890 - Adia Med of Winter Park LLC Chronic Kidney Disease Research Study) and the Lower Back Pain Study (NCT07587047 - Adia Med of Winter Park LLC Lower Back Pain Research Study) are evaluating the safety and preliminary efficacy of AdiaVita™ - Adia Med's proprietary umbilical cord blood-derived stem cell and exosome product - in adults with Stage 2-4 Chronic Kidney Disease and chronic lower back pain, respectively. Both studies include a patient-paid participation fee of $15,000 for the Kidney Health Study and $5,000 for the Lower Back Pain Study. These fees are designed to assist in offsetting the substantial costs associated with conducting the clinical trials. If both studies reach full enrollment, Adia Med anticipates receiving $1,500,000 from the Kidney Health Study and $500,000 from the Lower Back Pain Study, for a combined total of $2,...